Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study

…, JF Korobelnik, RO Schlingemann, R Axer-Siegel… - Ophthalmology, 2011 - Elsevier
OBJECTIVE:: To demonstrate noninferiority of a quarterly treatment regimen to a monthly
regimen of ranibizumab in patients with subfoveal choroidal neovascularization (CNV) …

Diabetic retinopathy during pregnancy

R Axer-Siegel, M Hod, S Fink-Cohen, M Kramer… - Ophthalmology, 1996 - Elsevier
Purpose: The purpose of the study is to evaluate the incidence, prevalence, progression,
and risk factors of diabetic retinopathy during pregnancy. Methods: Sixty-five patients who …

The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration

R Silva, R Axer-Siegel, B Eldem, R Guymer, B Kirchhof… - Ophthalmology, 2013 - Elsevier
OBJECTIVE: To evaluate long-term safety of intravitreal ranibizumab 0.5-mg injections in
neovascular age-related macular degeneration (nAMD). DESIGN: Twenty-four–month, open …

Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes

R Axer-Siegel, I Maharshak, M Snir, R Friling, R Ehrlich… - Retina, 2008 - journals.lww.com
Purpose: To examine the anatomical and refractive outcomes of infrared diode laser
photocoagulation (DLPC) for the treatment of threshold retinopathy of prematurity (ROP) …

Indocyanine green angiographic findings in nonproliferative diabetic retinopathy

…, M Kramer, E Priel, DD Gaton, R Axer-Siegel… - American journal of …, 1998 - Elsevier
PURPOSE: To report angiographic findings of nonproliferative diabetic retinopathy patients
by means of indocyanine green angiography. METHODS: Forty-two eyes (42 patients) with …

Retinopathy of prematurity in assisted versus natural conception and singleton versus multiple births

R Friling, R Axer-Siegel, Z Hersocovici, D Weinberger… - Ophthalmology, 2007 - Elsevier
OBJECTIVES: To determine whether the incidence and severity of retinopathy of prematurity
(ROP) differs between infants conceived naturally and those born after assisted conception …

Association of neovascular age-related macular degeneration and hyperhomocysteinemia

R Axer-Siegel, D Bourla, R Ehrlich, G Dotan… - American journal of …, 2004 - Elsevier
PURPOSE: To assess the relationship between plasma homocysteine levels and exudative
neovascular age-related macular degeneration (AMD). DESIGN: Cross-sectional study …

Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis

…, MR Kramer, H Blau, J Bishara, R Axer-Siegel… - Ophthalmology, 2006 - Elsevier
OBJECTIVE: To describe the first use of intravitreal voriconazole in a human eye for the
treatment of Aspergillus endophthalmitis. DESIGN: Interventional case report. PATIENT: A …

Refraction and keratometry in 40 week old premature (corrected age) and term infants

…, D Weinberger, I Sherf, R Axer-Siegel - British Journal of …, 2004 - bjo.bmj.com
Aim: To compare refraction and keratometry readings between premature and term babies
at 40 weeks' postconceptional age (PCA), and the possible effect of birth weight (BW) and …

[HTML][HTML] Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular …

…, E Averbukh, I Hemo, A Pollack, R Axer-Siegel… - Molecular …, 2008 - ncbi.nlm.nih.gov
Purpose Single nucleotide polymorphisms (SNPs) in the tightly linked LOC387715/ARMS2
and HTRA1 genes have been associated with age-related macular degeneration (AMD). We …